Pacesa Sa De Cv
FDA import alert and refusal historyProgreso, MexicoFEI 3003171376
As of October 25, 2026, Pacesa Sa De Cv (Progreso, Mexico) is on the red list of FDA Import Alert 16-81 (Seafood products: Salmonella) for snapper (red, gray, malabar, etc.), published by FDA on September 18, 2009, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 16-81 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Pacesa Sa De Cv
1 record, newest first. Each line links to the FDA page it came from.
2009
- Import alert listingListed on Import Alert 16-81red listSnapper (Red, Gray, Malabar, etc.)Source
Questions about Pacesa Sa De Cv
- Is Pacesa Sa De Cv on an FDA import alert?
- Yes. As of October 25, 2026, Pacesa Sa De Cv is on the red list of FDA Import Alert 16-81, “Seafood products: Salmonella”, for snapper (red, gray, malabar, etc.); FDA published the listing on September 18, 2009.
- Has FDA refused shipments from Pacesa Sa De Cv?
- No FDA import refusals for Pacesa Sa De Cv appear in FDA's refusal data since October 2016, as of October 25, 2026.
- What is Pacesa Sa De Cv's FEI number?
- Pacesa Sa De Cv's FDA Establishment Identifier (FEI) is 3003171376.
- Can shipments from Pacesa Sa De Cv still enter the U.S.?
- Shipments of snapper (red, gray, malabar, etc.) from Pacesa Sa De Cv can be detained without physical examination under Import Alert 16-81; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Pacesa Sa De Cv?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.